The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
Open accessAbstract
Background—: Cardiotoxicity is a leading cause for drug attrition during pharmaceutical development and has resulted in numerous preventable patient deaths. Incidents of adverse cardiac drug reactions are more common in patients with preexisting heart disease than the general population. Here we generated a library of human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) from patients with various hereditary cardiac disorders to model differences in cardiac drug toxicity susceptibility for patients of different genetic backgrounds. Methods and Results—: Action potential duration and drug-induced arrhythmia were measured at the single cell level in hiPSC-CMs derived from healthy subjects and patients with hereditary long QT syndrome, familial hypertrophic cardiomyopathy, and familial dilated cardiomyopathy. Disease phenotypes were verified in long QT syndrome, hypertrophic cardiomyopathy, and dilated cardiomyopathy hiPSC-CMs by immunostaining and single cell patch clamp. Human embryonic stem cell–derived cardiomyocytes (hESC-CMs) and the human ether-a-go-go –related gene expressing human embryonic kidney cells were used as controls. Single cell PCR confirmed expression of all cardiac ion channels in patient-specific hiPSC-CMs as well as hESC-CMs, but not in human embryonic kidney cells. Disease-specific hiPSC-CMs demonstrated increased susceptibility to known cardiotoxic drugs as measured by action potential duration and quantification of drug-induced arrhythmias such as early afterdepolarizations and delayed afterdepolarizations. Conclusions—: We have recapitulated drug-induced cardiotoxicity profiles for healthy subjects, long QT syndrome, hypertrophic cardiomyopathy, and dilated cardiomyopathy patients at the single cell level for the first time. Our data indicate that healthy and diseased individuals exhibit different susceptibilities to cardiotoxic drugs and that use of disease-specific hiPSC-CMs may predict adverse drug responses more accurately than the standard human ether-a-go-go –related gene test or healthy control hiPSC-CM/hESC-CM screening assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
International Conference on Harmonisation
Guy, R. C. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,478
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Classen, D. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280039031 · Cited by 1,134
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,001
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734
Self-citationPatient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
Self-citationPatient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
Self-citationLan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
Self-citationThe impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Adverse drug events in hospitalized patients
van den Bemt, P. M. L. A., Egberts, A. C. G., Lenderink, A. W., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., & Leufkens, H. G. M. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050611 · Cited by 460
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells
Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.-H., & Gepstein, L. (2009) · Circulation · doi:10.1161/circulationaha.109.868885 · Cited by 435
Jost, N., Virág, L., Bitay, M., Takács, J., Lengyel, C., Biliczki, P., Nagy, Z., Bogáts, G., Lathrop, D. A., Papp, J. G., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.550111 · Cited by 397
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., & Mummery, C. L. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.11.004 · Cited by 368
Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels
Zhang, S., Zhou, Z., Gong, Q., Makielski, J. C., & January, C. T. (1999) · Circulation Research · doi:10.1161/01.res.84.9.989 · Cited by 366
KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome
Donger, C., Denjoy, I., Berthet, M., Neyroud, N., Cruaud, C., Bennaceur, M., Chivoret, G., Schwartz, K., Coumel, P., & Guicheney, P. (1997) · Circulation · doi:10.1161/01.cir.96.9.2778 · Cited by 348
Jung, C. B., Moretti, A., Mederos y Schnitzler, M., Iop, L., Storch, U., Bellin, M., Dorn, T., Ruppenthal, S., Pfeiffer, S., Goedel, A., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100194 · Cited by 327
Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action
Smalley, W., Shatin, D., Wysowski, D. K., Gurwitz, J., Andrade, S. E., Goodman, M., Chan, K. A., Platt, R., Schech, S. D., & Ray, W. A. (2000) · JAMA · doi:10.1001/jama.284.23.3036 · Cited by 255
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S. R., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14677 · Cited by 250
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice
Baudenbacher, F., Schober, T., Pinto, J. R., Sidorov, V. Y., Hilliard, F., Solaro, R. J., Potter, J. D., & Knollmann, B. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36642 · Cited by 248
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
De Bruin, M. L., Pettersson, M., Meyboom, R. H. B., Hoes, A. W., & Leufkens, H. G. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi092 · Cited by 245
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214677 · Cited by 235
Drug-induced long QT and torsade de pointes: recent advances
Kannankeril, P. J., & Roden, D. M. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32801129eb · Cited by 227
Itzhaki, I., Maizels, L., Huber, I., Gepstein, A., Arbel, G., Caspi, O., Miller, L., Belhassen, B., Nof, E., Glikson, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.066 · Cited by 223
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Caspi, O., Itzhaki, I., Kehat, I., Gepstein, A., Arbel, G., Huber, I., Satin, J., & Gepstein, L. (2009) · Stem Cells and Development · doi:10.1089/scd.2007.0280 · Cited by 221
Silva, J., & Rudy, Y. (2005) · Circulation · doi:10.1161/circulationaha.105.543306 · Cited by 213
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Peng, S., Lacerda, A. E., Kirsch, G. E., Brown, A. M., & Bruening-Wright, A. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.01.014 · Cited by 183
Shimizu, W., & Antzelevitch, C. (2000) · Circulation · doi:10.1161/01.cir.102.6.706 · Cited by 182
Lu, Z., Wu, C.-Y. C., Jiang, Y.-P., Ballou, L. M., Clausen, C., Cohen, I. S., & Lin, R. Z. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003623 · Cited by 172
Hoffmann, P., & Warner, B. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.07.003 · Cited by 167
Yokoo, N., Baba, S., Kaichi, S., Niwa, A., Mima, T., Doi, H., Yamanaka, S., Nakahata, T., & Heike, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.052 · Cited by 165
Embryonic stem cells in drug discovery
McNeish, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1281 · Cited by 165
Shimizu, W., Ohe, T., Kurita, T., Kawade, M., Arakaki, Y., Aihara, N., Kamakura, S., Kamiya, T., & Shimomura, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00313-4 · Cited by 164
Jonsson, M. K. B., Vos, M. A., Mirams, G. R., Duker, G., Sartipy, P., de Boer, T. P., & van Veen, T. A. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.002 · Cited by 138
Lu, H.-R., Vlaminckx, E., Hermans, A. N., Rohrbacher, J., van Ammel, K., Towart, R., Pugsley, M., & Gallacher, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.191 · Cited by 131
Mechanisms and management of proarrhythmia
Roden, D. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00472-x · Cited by 127
Davis, R. P., van den Berg, C. W., Casini, S., Braam, S. R., & Mummery, C. L. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.001 · Cited by 126
Pharmacogenetics and drug-induced arrhythmias
Roden, D. M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00302-3 · Cited by 121
Molecular basis of species-specific expression of repolarizing K+currents in the heart
Zicha, S., Moss, I. L., Allen, B. G., Varró, A., Papp, J. G., Dumaine, R., Antzelevich, C., & Nattel, S. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00346.2003 · Cited by 120
Otsuji, T. G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., & Nakatsuji, N. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.01.002 · Cited by 117
Shah, R. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00191.x · Cited by 111
Population-Based Studies of Adverse Drug Effects
Ray, W. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038145 · Cited by 106
Protecting the Heart Against Arrhythmias: Potassium Current Physiology and Repolarization Reserve
Roden, D. M., & Yang, T. (2005) · Circulation · doi:10.1161/circulationaha.105.562777 · Cited by 105
Strategies to reduce late-stage drug attrition due to mitochondrial toxicity
Dykens, J. A., Marroquin, L. D., & Will, Y. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.161 · Cited by 95
Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism
Lacerda, A. E., Kuryshev, Y. A., Chen, Y., Renganathan, M., Eng, H. F., Danthi, S. J., Kramer, J., Yang, T., & Brown, A. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128405 · Cited by 91
Honda, M., Kiyokawa, J., Tabo, M., & Inoue, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11038fp · Cited by 89
Braam, S. R., Tertoolen, L. G. J., Casini, S., Matsa, E., Lu, H. R., Teisman, A. C. H., Passier, R. C., Denning, C. N., Gallacher, D. J., Towart, R., et al. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.08.007 · Cited by 78
Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation
Saumarez, R. C., Chojnowska, L., Derksen, R., Pytkowski, M., Sterlinski, M. M., Huang, C. L.-H., Sadoul, N., Hauer, R. N. W., Rużyłło, W., & Grace, A. A. (2003) · Circulation · doi:10.1161/01.cir.0000068342.96569.a1 · Cited by 72
Clinical assessment of drug-induced QT prolongation in association with heart rate changes
Extramiana, F., Maison‐Blanche, P., CABANIS, M., Ortemann‐Renon, C., Beaufils, P., & Leenhardt, A. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.016 · Cited by 68
Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
Jonsson, M. K. B., Duker, G., Tropp, C., Andersson, B., Sartipy, P., Vos, M. A., & van Veen, T. A. B. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.02.001 · Cited by 65
van Noord, C., Sturkenboom, M., Straus, S. M. J. M., Witteman, J. C. M., & Stricker, B. H. C. (2010) · Heart · doi:10.1136/hrt.2009.188367 · Cited by 53
Takahashi, N., Ito, M., Saikawa, T., & Arita, M. (1991) · Cardiovascular Research · doi:10.1093/cvr/25.6.445 · Cited by 52
Potassium channel openers are likely to be proarrhythmic in the diseased human heart
Black, S., & Lucchesi, B. R. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.6.923 · Cited by 24
Cited by
Screening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Lewis-Israeli, Y. R., Wasserman, A. H., Gabalski, M. A., Volmert, B. D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25329-5 · Cited by 536
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 519
Karakikes, I., Ameen, M., Termglinchan, V., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.117.305365 · Cited by 478
Self-citationHuman cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity
Richards, D. J., Li, Y., Kerr, C. M., Yao, J., Beeson, G. C., Coyle, R. C., Chen, X., Jia, J., Damon, B., Wilson, R., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0539-4 · Cited by 439
Metadata
- Authors
- Liang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., Nguyen, P. K., Bers, D. M., Robbins, R. C., & Wu, J. C.
- Venue
- Circulation
- Published
- 2013-04-23
- Volume
- 127
- Issue
- 16
- Pages
- 1677-1691
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975396117
- Cited by
- 537
- References
- 58
- FWCI
- 41.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.